|
C17ORF39 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.446820E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.337710E-03 |
| Normal-vs-Stage2 |
2.051000E-01 |
| Normal-vs-Stage3 |
3.36430000003052E-06 |
| Normal-vs-Stage4 |
5.761100E-04 |
| Stage1-vs-Stage2 |
1.389980E-01 |
| Stage1-vs-Stage3 |
1.883540E-02 |
| Stage1-vs-Stage4 |
1.580830E-01 |
| Stage2-vs-Stage3 |
2.602500E-03 |
| Stage2-vs-Stage4 |
2.387800E-02 |
| Stage3-vs-Stage4 |
7.460600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.77910000001658E-06 |
| Normal-vs-AfricanAmerican |
2.935400E-01 |
| Normal-vs-Asian |
4.392200E-02 |
| Caucasian-vs-AfricanAmerican |
1.527380E-01 |
| Caucasian-vs-Asian |
8.971600E-02 |
| AfricanAmerican-vs-Asian |
6.411000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.185200E-04 |
| Normal-vs-Female |
4.238600E-04 |
| Male-vs-Female |
6.203600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.543000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.575400E-04 |
| Normal-vs-Age(61-80Yrs) |
7.618700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.417180E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.824600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.821000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.709700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.329200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.853600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.907700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.008600E-04 |
| Classical-VS-Follicular |
7.718300E-03 |
| Classical-VS-Other |
8.775800E-01 |
| Classical-VS-Normal |
1.954090E-04 |
| Tall-VS-Follicular |
1.57509999998418E-06 |
| Tall-VS-Other |
6.958300E-02 |
| Tall-VS-Normal |
1.94519999996423E-07 |
| Follicular-VS-Other |
5.088800E-01 |
| Follicular-VS-Normal |
2.120000E-01 |
| Other-VS-Normal |
2.256400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.801980E-03 |
| Normal-vs-N1 |
3.53659999999811E-05 |
| N0-vs-N1 |
1.647610E-02 |
|
|
